2415004
Project Grant
Overview
Grant Description
Sbir Phase I: Unlocking the full potential of next-generation expansion microscopy through automation -the broader impact/commercial potential of this small business innovation research (SBIR) Phase I project stems from addressing critical barriers in nanoscale bioimaging? Specifically, the prohibitive costs, technical complexities, and specialized expertise required for super-resolution and electron microscopes, which range from hundreds of thousands to several million dollars with sample preparation costs up to thousands and processing times exceeding a week.
This project introduces a transformative solution by automating magnify expansion microscopy into a cost-effective device, enabling conventional optical microscopes to achieve detailed biological insights at the nanoscale. By reducing sample preparation costs to under $10 and cutting processing times to less than a day, this technology will democratize nanoscale imaging, expanding research capabilities across various scientific domains. It enables researchers in labs without advanced microscopes to explore molecular and structural changes in diseases, discover new biomarkers, and develop diagnostic and prognostic tests.
Societal benefits include pioneering discoveries in untapped territories, innovative diagnostic and prognostic tools, and significant healthcare cost reductions. Commercially, equipping existing microscopes with the Automagnify device is set to revolutionize the high-end microscopy market, potentially creating a billion-dollar industry by dramatically enhancing speed, cost-effectiveness, and ease of use, paralleling the transformative advancements seen in next-generation sequencing in genomics. This small business innovation research (SBIR) Phase I project aims to develop an automated Automagnify device that physically expands biological specimens up to 1000 times in isotropically in 3-dimensions, while preserving their spatial and molecular integrity.
This advancement will enable conventional light microscopes to achieve imaging resolutions down to 25 nm, capabilities typically reserved for super-resolution and electron microscopy. By shifting the focus from costly optical enhancements to physical specimen magnification, this project offers a practical, scalable solution for widespread nanoscale bioimaging. The Automagnify system reduces the sample preparation time from traditionally over a week to less than 24 hours, dramatically lowering both the financial and technical thresholds for super-resolution imaging.
This project builds upon foundational magnify expansion microscopy techniques to develop new rapid protocols and leverage durable gel compositions that address machine handling and reliability issues. The expected result is a fully functional prototype that standardizes sample preparation and staining protocols, enabling researchers in academia and pharmaceutical companies using conventional microscopes to access super-resolution quality images for their discovery needs. This pivotal innovation not only makes advanced imaging techniques more accessible but also significantly extends the research capabilities of scientific laboratories globally, potentially redefining the landscape of nanoscale imaging.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- Subawards are not planned for this award.
This project introduces a transformative solution by automating magnify expansion microscopy into a cost-effective device, enabling conventional optical microscopes to achieve detailed biological insights at the nanoscale. By reducing sample preparation costs to under $10 and cutting processing times to less than a day, this technology will democratize nanoscale imaging, expanding research capabilities across various scientific domains. It enables researchers in labs without advanced microscopes to explore molecular and structural changes in diseases, discover new biomarkers, and develop diagnostic and prognostic tests.
Societal benefits include pioneering discoveries in untapped territories, innovative diagnostic and prognostic tools, and significant healthcare cost reductions. Commercially, equipping existing microscopes with the Automagnify device is set to revolutionize the high-end microscopy market, potentially creating a billion-dollar industry by dramatically enhancing speed, cost-effectiveness, and ease of use, paralleling the transformative advancements seen in next-generation sequencing in genomics. This small business innovation research (SBIR) Phase I project aims to develop an automated Automagnify device that physically expands biological specimens up to 1000 times in isotropically in 3-dimensions, while preserving their spatial and molecular integrity.
This advancement will enable conventional light microscopes to achieve imaging resolutions down to 25 nm, capabilities typically reserved for super-resolution and electron microscopy. By shifting the focus from costly optical enhancements to physical specimen magnification, this project offers a practical, scalable solution for widespread nanoscale bioimaging. The Automagnify system reduces the sample preparation time from traditionally over a week to less than 24 hours, dramatically lowering both the financial and technical thresholds for super-resolution imaging.
This project builds upon foundational magnify expansion microscopy techniques to develop new rapid protocols and leverage durable gel compositions that address machine handling and reliability issues. The expected result is a fully functional prototype that standardizes sample preparation and staining protocols, enabling researchers in academia and pharmaceutical companies using conventional microscopes to access super-resolution quality images for their discovery needs. This pivotal innovation not only makes advanced imaging techniques more accessible but also significantly extends the research capabilities of scientific laboratories globally, potentially redefining the landscape of nanoscale imaging.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.- Subawards are not planned for this award.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE I", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF23515
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Sewickley,
Pennsylvania
15143-8557
United States
Geographic Scope
Single Zip Code
Magnify Biosciences was awarded
Project Grant 2415004
worth $274,998
from National Science Foundation in June 2024 with work to be completed primarily in Sewickley Pennsylvania United States.
The grant
has a duration of 1 year and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
The Project Grant was awarded through grant opportunity NSF Small Business Innovation Research / Small Business Technology Transfer Phase I Programs.
SBIR Details
Research Type
SBIR Phase I
Title
SBIR Phase I: Unlocking the Full Potential of Next-Generation Expansion Microscopy through Automation
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project stems from addressing critical barriers in nanoscale bioimaging—specifically, the prohibitive costs, technical complexities, and specialized expertise required for super-resolution and electron microscopes, which range from hundreds of thousands to several million dollars with sample preparation costs up to thousands and processing times exceeding a week. This project introduces a transformative solution by automating Magnify Expansion Microscopy into a cost-effective device, enabling conventional optical microscopes to achieve detailed biological insights at the nanoscale. By reducing sample preparation costs to under $10 and cutting processing times to less than a day, this technology will democratize nanoscale imaging, expanding research capabilities across various scientific domains. It enables researchers in labs without advanced microscopes to explore molecular and structural changes in diseases, discover new biomarkers, and develop diagnostic and prognostic tests. Societal benefits include pioneering discoveries in untapped territories, innovative diagnostic and prognostic tools, and significant healthcare cost reductions. Commercially, equipping existing microscopes with the AutoMagnify device is set to revolutionize the high-end microscopy market, potentially creating a billion-dollar industry by dramatically enhancing speed, cost-effectiveness, and ease of use, paralleling the transformative advancements seen in next-generation sequencing in genomics.
This Small Business Innovation Research (SBIR) Phase I project aims to develop an automated AutoMagnify device that physically expands biological specimens up to 1000 times in isotropically in 3-dimensions, while preserving their spatial and molecular integrity. This advancement will enable conventional light microscopes to achieve imaging resolutions down to 25 nm, capabilities typically reserved for super-resolution and electron microscopy. By shifting the focus from costly optical enhancements to physical specimen magnification, this project offers a practical, scalable solution for widespread nanoscale bioimaging. The AutoMagnify system reduces the sample preparation time from traditionally over a week to less than 24 hours, dramatically lowering both the financial and technical thresholds for super-resolution imaging. This project builds upon foundational Magnify Expansion Microscopy techniques to develop new rapid protocols and leverage durable gel compositions that address machine handling and reliability issues. The expected result is a fully functional prototype that standardizes sample preparation and staining protocols, enabling researchers in academia and pharmaceutical companies using conventional microscopes to access super-resolution quality images for their discovery needs. This pivotal innovation not only makes advanced imaging techniques more accessible but also significantly extends the research capabilities of scientific laboratories globally, potentially redefining the landscape of nanoscale imaging.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
BM
Solicitation Number
NSF 23-515
Status
(Complete)
Last Modified 6/20/24
Period of Performance
6/15/24
Start Date
5/31/25
End Date
Funding Split
$275.0K
Federal Obligation
$0.0
Non-Federal Obligation
$275.0K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2415004
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
UYGVDZDSW9Q3
Awardee CAGE
None
Performance District
PA-17
Senators
Robert Casey
John Fetterman
John Fetterman
Modified: 6/20/24